Akari Therapeutics Plc

1.80 USD
-1.01 (-35.94%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Akari Therapeutics Plc stock is up 18.42% since 30 days ago. The next earnings date is Sep 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 8 June’s closed higher than May.

About Akari Therapeutics Plc

Akari Therapeutics, Plc focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities.